Nathan Cortez
Nathan Cortez

Nathan Cortez, a Professor at SMU Law School, has spent over 20 years teaching and writing about the law governing the biotech and health care industries, focusing on FDA regulation and novel technologies. He is coauthor of the leading casebook on Food & Drug Law. He has also published extensive research on federal data policy, the regulatory uses of information, and regulation of commercial speech under the First Amendment.

Columns by Nathan Cortez
Bad Friday: Federal Judge Rules that 23-Year-Old FDA Approval of Abortion Drug Was Invalid

Stanford Law visiting professor Joanna L. Grossman, SMU Law professor Nathan Cortez, and SMU Law professor Seema Mohapatra critique the ruling last week by federal judge Matthew Kacsmaryk issuing a preliminary injunction to “delay” the FDA’s approval of mifepristone, one of the two drugs used in medication abortion. Professors Grossman, Cortez, and Mohapatra explore some of the deepest flaws in Judge Kacsmaryk’s opinion and the ways he manipulated law, science, and language to hew closely to the anti-abortion playbook.